SCHEMBL2878936

SCHEMBL2878936

CC1CCC(C(=O)N(CC2CCN(C)CC2)c2cc(-c3ccccc3)sc2OC(=O)O)CC1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MKNK1 Q9BUB5 1/20 0.38
▸ CHEK1 O14757 1/20 0.35
▸ HDAC1 Q13547 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ ATM Q13315 1/20 0.34
▸ USP30 Q70CQ3 1/20 0.34
▸ HRH3 Q9Y5N1 3/20 0.34
▸ PKM P14618 2/20 0.34
▸ HDAC2 Q92769 1/20 0.34
▸ NPR1 P16066 1/20 0.34
▸ CHRM3 P20309 2/20 0.33
▸ SCN1A P35498 1/20 0.33
▸ SCN2A Q99250 1/20 0.33
▸ SCN3A Q9NY46 1/20 0.33
▸ HTR6 P50406 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2876357 0.88 CYP2E1 (0.42) MKNK1CHEK1HDAC1KDM4EHTT
Hydrochloric Acid SCHEMBL2874873 0.87 CYP2E1 (0.41) MKNK1CHEK1HDAC1KDM4EHTT
SCHEMBL2870751 0.86 KDM4E (0.47) MKNK1KDM4EHTTATMCHRM3
SCHEMBL14030874 0.86 MKNK1 (0.37) MKNK1CHEK1HDAC1KDM4EHTT
SCHEMBL3807589 0.84 MKNK1 (0.39) MKNK1CHEK1KDM4EHTTATM
SCHEMBL2878325 0.84 HTT (0.36) KDM4EHTTATMUSP30
SCHEMBL2157834 0.80 CYP2E1 (0.43) KDM4EHTTATMUSP30PKM
SCHEMBL2877042 0.79 NR1I2 (0.41) CHEK1KDM4EHTTATM
SCHEMBL3812146 0.79 KDM4E (0.41) KDM4EHTTATMUSP30
SCHEMBL2881334 0.79 CPB1 (0.42) KDM4EHTTATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1569929-B9 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS VIROCHEM PHARMA INC (CA) 2011-09-14 — — EP claimed
EP-1569929-B1 COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS VIROCHEM PHARMA INC (CA) 2010-05-05 — — EP claimed
Send feedback